Visual outcomes with implantable Collamer lens versus small incision lenticule extraction in moderate-high myopia: A pilot study

作者
Rajesh Sinha,Juhi Daga,Pranita Sahay,Vinay Gupta,Tushar Agarwal,Namrata Sharma,Prafulla Kumar Maharana,Sudarshan Kumar Khokhar,Jeewan Singh Titiyal
出处
期刊:Indian Journal of Ophthalmology [Medknow]
卷期号:73 (1): 115-121 被引量:2
标识
DOI:10.4103/ijo.ijo_908_24
摘要

PURPOSE: To compare the visual outcomes of implantable Collamer lens (ICL) with small incision lenticule extraction (SMILE) in cases of moderate-high myopia. METHODS: A prospective comparative study was conducted on 60 eyes of 30 patients with moderate-high myopia (-3D to -8D with astigmatism ≤1 D) at a tertiary eye care center. Patients underwent either SMILE or ICL in both eyes and had a postoperative follow-up of 1 year. RESULTS: The manifest refractive spherical equivalent was -5.22 ± 1.05 D and -5.4 ± 1.17 D in the SMILE and ICL groups, respectively ( P = 0.53). The mean sphere and cylinder were comparable between the groups. The mean uncorrected visual acuity improved from 1.18 ± 0.19 logMAR to 0.03 ± 0.07 logMAR in SMILE and 1.14 ± 0.25 logMAR to 0.011 ± 0.04 logMAR in the ICL group. The efficacy for SMILE was 83.3% and that for ICL was 93.3%. Safety and predictability (±0.5D) for both was 100%. A significant increase was observed in ocular aberration with a decrease in modular transfer function in the eyes that underwent SMILE, whereas no significant change in the eyes that underwent ICL. A significant difference was observed in all parameters of ocular aberration except corneal trefoil, corneal astigmatism, and PSF between the two groups at the final follow-up. The contrast sensitivity at final follow-up was higher in ICL cases when compared to SMILE. The quality of vision (QoV) score suggested a better QoV with ICL; however, the difference was not statistically significant. CONCLUSION: Both SMILE and ICL are safe in patients with moderate-high myopia. The efficacy, contrast sensitivity, and postoperative ocular aberration profile are better in cases undergoing ICL.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
yehata发布了新的文献求助10
1秒前
NexusExplorer的应助被光影相生采纳,获得10
1秒前
洛泱完成签到 ,获得积分10
1秒前
1秒前
2秒前
Jasper的应助被肖潇雨歇采纳,获得10
2秒前
科研通AI6.2的应助被体贴香岚采纳,获得10
2秒前
琦琦发布了新的文献求助10
2秒前
蛋坏坏完成签到 ,获得积分10
4秒前
诺阳完成签到,获得积分10
5秒前
务觅的应助被CYQ采纳,获得30
5秒前
荷去发布了新的文献求助30
6秒前
7秒前
7秒前
彩色泽洋发布了新的文献求助10
7秒前
ltt发布了新的文献求助10
8秒前
琦琦完成签到,获得积分20
8秒前
灯笔忆扬完成签到 ,获得积分10
9秒前
Mixtral完成签到,获得积分10
10秒前
10秒前
科研通AI6.2的应助被y09采纳,获得10
11秒前
prinzt完成签到,获得积分10
11秒前
斯文败类的应助被勤劳的安阳采纳,获得10
11秒前
夕沫完成签到,获得积分10
11秒前
6666的应助被Watson采纳,获得10
11秒前
11秒前
aaa完成签到,获得积分10
11秒前
YaoHui发布了新的文献求助10
11秒前
传奇3的应助被yehata采纳,获得30
13秒前
real发布了新的文献求助10
13秒前
cql完成签到 ,获得积分10
14秒前
CYQ对应助文件撤销了驳回
14秒前
makemesway发布了新的文献求助10
14秒前
mingga完成签到,获得积分10
15秒前
NexusExplorer的应助被小超超采纳,获得10
15秒前
天天快乐的应助被学术丁真采纳,获得10
16秒前
李开心发布了新的文献求助10
16秒前
今后的应助被LY采纳,获得10
17秒前
兽先生完成签到 ,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Représentation chimique de la structure des kérogènes et des asphaltènes en fonction de leur origine et de leur degré d'évolution 900
Ecotourism 400
Analytical Separation Science 300
Civilization and War 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8068653
求助须知:如何正确求助?哪些是违规求助? 9490071
关于积分的说明 21356710
捐赠科研通 7637111
什么是DOI,文献DOI怎么找? 3398428
关于科研通互助平台的介绍 2528267
邀请新用户注册赠送积分活动 2436302